Invest now
Emcure Pharmaceuticals Cash Flow Annual
BSE: 544210 | NSE: EMCURE | ISIN: INE168P01015 | Sector: Biotechnology & Drugs1,926.00 -1.15 (-0.06%)Updated : 08 Sep 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Issuance( Retirement)of Debt Net | 488.43 | -1,464.51 | 119.00 | 77.52 |
| Net Changein Cash | 112.08 | -58.30 | 218.52 | 133.64 |
| Cash Taxes Paid | 368.08 | 246.86 | 223.65 | 200.48 |
| Net Income/ Starting Line | 1,287.14 | 971.35 | 727.23 | 747.21 |
| Total Cash Dividends Paid | -56.85 | - | - | - |
| Changesin Working Capital | -898.21 | -671.16 | -173.14 | -492.71 |
| Cashfrom Operating Activities | 943.55 | 851.70 | 1,097.24 | 746.85 |
| Cash Interest Paid | 94.79 | 128.68 | 208.18 | 178.56 |
| Cashfrom Financing Activities | 343.43 | -813.96 | -164.21 | -145.40 |
| Issuance( Retirement)of Stock Net | 6.65 | 779.23 | -12.58 | - |
| Depreciation/ Depletion | 415.05 | 384.13 | 312.41 | 260.12 |
| Other Investing Cash Flow Items Total | -645.37 | 312.93 | -405.38 | -64.32 |
| Capital Expenditures | -547.69 | -406.93 | -307.13 | -403.36 |
| period Type | - | - | - | - |
| Foreign Exchange Effects | 18.16 | -2.05 | -2.00 | -0.13 |
| Non- Cash Items | 139.57 | 167.38 | 230.74 | 232.23 |
| Financing Cash Flow Items | -94.79 | -128.68 | -270.63 | -222.92 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -1,193.05 | -94.00 | -712.51 | -467.69 |
*All figures in crores except per share values
Emcure Pharmaceuticals Quick Links
Emcure Pharmaceuticals Dividend Emcure Pharmaceuticals Bonus Emcure Pharmaceuticals News Emcure Pharmaceuticals AGM Emcure Pharmaceuticals Rights Emcure Pharmaceuticals Splits Emcure Pharmaceuticals Board Meetings Emcure Pharmaceuticals Key Metrics Emcure Pharmaceuticals Shareholdings Emcure Pharmaceuticals Profit Loss Emcure Pharmaceuticals Balance Sheet Emcure Pharmaceuticals Q1 Results Emcure Pharmaceuticals Q2 Results Emcure Pharmaceuticals Q3 Results Emcure Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
410.50+6.00(1.48%)
1,708.85+17.85(1.06%)
1,982.50+16.50(0.84%)
1,399.50-28.50 (-2.00%)
1,245.45-21.85 (-1.72%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.